Oral 5-Aminosalicyclic Acid Versus 6-Methylprednisolone in Active Crohn's Disease
The response to 5-aminosalicylic acid (5-ASA) in active Crohn's disease was studied in comparison to methylprednisolone in a 24 week randomized double-blind multicentre study. Sixty-two patients were included in the analysis. Thirty were treated with 500 mg 5-ASA qid and 32 with methylprednisol...
Saved in:
Main Authors: | Jürgen Schölmerich, Harro Jenss, Franz Hartmann, Hanne Döpfer, The German 5-ASA Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1990-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1990/260563 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Trial of Remission Prophylaxis in Quiescent Crohn’s Disease with Oral 4-Aminosalicyclic Acid Versus 5-Aminosalicylic Acid Slow Release Tablets
by: Stefanie Howaldt, et al.
Published: (1993-01-01) -
Methylprednisolone Therapy in Acute Hemorrhagic Edema of Infancy
by: Jeyanthini Risikesan, et al.
Published: (2014-01-01) -
DRESS Syndrome due to Nevirapine Treated with Methylprednisolone
by: Henrique Pott Junior, et al.
Published: (2013-01-01) -
Preventive Treatment with Methylprednisolone Paradoxically Exacerbates Experimental Autoimmune Encephalomyelitis
by: Simone Wüst, et al.
Published: (2012-01-01) -
Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves’ Orbitopathy
by: Piotr Miśkiewicz, et al.
Published: (2018-01-01)